Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
326.10
+0.52
(+0.16%)
Pre-Market: 09:18
Bio-Rad Laboratories Debt to Equity Ratio: 0.1604 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1604 |
| June 30, 2024 | 0.1756 |
| March 31, 2024 | 0.1315 |
| December 31, 2023 | 0.1372 |
| September 30, 2023 | 0.1413 |
| June 30, 2023 | 0.1419 |
| March 31, 2023 | 0.1228 |
| December 31, 2022 | 0.1246 |
| September 30, 2022 | 0.1404 |
| June 30, 2022 | 0.133 |
| March 31, 2022 | 0.1165 |
| December 31, 2021 | 0.0008 |
| September 30, 2021 | 0.0001 |
| June 30, 2021 | 0.0001 |
| March 31, 2021 | 0.0001 |
| December 31, 2020 | 0.0003 |
| September 30, 2020 | 0.0484 |
| June 30, 2020 | 0.0581 |
| March 31, 2020 | 0.0679 |
| December 31, 2019 | 0.0744 |
| September 30, 2019 | 0.0834 |
| June 30, 2019 | 0.078 |
| March 31, 2019 | 0.0879 |
| December 31, 2018 | 0.1093 |
| September 30, 2018 | 0.0899 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.095 |
| March 31, 2018 | 0.0969 |
| December 31, 2017 | 0.1485 |
| September 30, 2017 | 0.1527 |
| June 30, 2017 | 0.1547 |
| March 31, 2017 | 0.1606 |
| December 31, 2016 | 0.1685 |
| September 30, 2016 | 0.1607 |
| June 30, 2016 | 0.1661 |
| March 31, 2016 | 0.1707 |
| December 31, 2015 | 0.1743 |
| September 30, 2015 | 0.1795 |
| June 30, 2015 | 0.1848 |
| March 31, 2015 | 0.1983 |
| December 31, 2014 | 0.1995 |
| September 30, 2014 | 0.2009 |
| June 30, 2014 | 0.1944 |
| March 31, 2014 | 0.1959 |
| December 31, 2013 | 0.20 |
| September 30, 2013 | 0.2058 |
| June 30, 2013 | 0.3547 |
| March 31, 2013 | 0.3615 |
| December 31, 2012 | 0.3643 |
| September 30, 2012 | 0.3786 |
| June 30, 2012 | 0.3957 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0001
Minimum
Mar 2021
0.1756
Maximum
Jun 2024
0.0888
Average
0.1197
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies Inc | 0.4967 |
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Bionano Genomics Inc | 0.306 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.60B |
| Total Liabilities (Quarterly) | 3.116B |
| Shareholders Equity (Quarterly) | 7.488B |
| Current Ratio | 6.136 |
| Net Debt Paydown Yield | -0.01% |